1. GCB-type is a favorable prognostic factor in primary CNS diffuse large B-cell lymphomas
   Chelsea Marcus et al, 2021, Journal of Clinical Neuroscience CrossRef
2. Primary central nervous system lymphoma in China: a single-center retrospective analysis of 167 cases
   Xiang-Gui Yuan et al, 2020, Annals of Hematology CrossRef
3. MRI radiomics-based interpretable model and nomogram for preoperative prediction of Ki-67 expression status in primary central nervous system lymphoma
   Endong Zhao et al, 2024, Frontiers in Medicine CrossRef
4. Diffusion-weighted MR imaging histogram analysis in HIV positive and negative patients with primary central nervous system lymphoma as a predictor of outcome and tumor proliferation
   Bilal Khan et al, 2020, Oncotarget CrossRef
5. The Correlation Between Apparent Diffusion Coefficient (ADC) and Relative Cerebral Blood Volume (rCBV) with Ki-67 Expression in Central Nervous System Lymphoma
   Nguyen Duy Hung et al, 2020, International Journal of Cancer Management CrossRef
6. Primary central nervous system lymphoma: clinicopathological and genomic insights for therapeutic development
   Kensuke Tateishi et al, 2021, Brain Tumor Pathology CrossRef
7. Clinical Impact of the Histopathological Index and Neuroimaging Features Status in Primary Central Nervous System Diffuse Large B-Cell Lymphoma: A Single-Center Retrospective Analysis of 51 Cases
   Zhou Qi et al, 2022, Frontiers in Oncology CrossRef
8. Sentinel lesion and significance of rebiopsy: a case of primary CNS lymphoma
   Dominik Drobisz et al, 2022, Neurologie pro praxi CrossRef
9. Extranodal lymphoma: pathogenesis, diagnosis and treatment
   Hua Yang et al, 2023, Molecular Biomedicine CrossRef
10. Analysis of Cellular Heterogeneity in Immune Microenvironment of Primary Central Nervous System Lymphoma by Single-Cell Sequencing
    Boyuan Wei et al, 2021, Frontiers in Oncology CrossRef
11. Primary extranodal diffuse large B‐cell lymphoma: Molecular features, treatment, and prognosis
    Si‐Yuan Chen et al, 2022, Aging and Cancer CrossRef
12. Bruton’s tyrosine kinase inhibitors in the treatment of primary central nervous system lymphoma: A mini-review
    Jing Shen et al, 2022, Frontiers in Oncology CrossRef
13. Prognostic significance of immunohistochemical markers in Primary CNS lymphomas
    Indu Ramachandran Nair et al, 2021, IP Archives of Cytology and Histopathology Research CrossRef